Page last updated: 2024-11-03
probenecid and Bronchiectasis
probenecid has been researched along with Bronchiectasis in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Bronchiectasis: Persistent abnormal dilatation of the bronchi.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Allen, MB | 1 |
Fitzpatrick, RW | 1 |
Barratt, A | 1 |
Cole, RB | 1 |
Trials
1 trial available for probenecid and Bronchiectasis
Article | Year |
---|---|
The use of probenecid to increase the serum amoxycillin levels in patients with bronchiectasis.
Topics: Adult; Aged; Amoxicillin; Bronchiectasis; Drug Administration Schedule; Drug Therapy, Combination; F | 1990 |